| Mechanosensors in integrin signaling: the emerging role of p130Cas R Janoštiak, AC Pataki, J Brábek, D Rösel European journal of cell biology 93 (10-12), 445-454, 2014 | 152 | 2014 |
| CAS directly interacts with vinculin to control mechanosensing and focal adhesion dynamics R Janoštiak, J Brábek, V Auernheimer, Z Tatárová, LA Lautscham, T Dey, ... Cellular and molecular life sciences 71, 727-744, 2014 | 79 | 2014 |
| MELK promotes melanoma growth by stimulating the NF-κB pathway R Janostiak, N Rauniyar, TKT Lam, J Ou, LJ Zhu, MR Green, ... Cell reports 21 (10), 2829-2841, 2017 | 77 | 2017 |
| KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity R Gupta, P Malvi, KR Parajuli, R Janostiak, S Bugide, G Cai, LJ Zhu, ... Proceedings of the National Academy of Sciences 117 (22), 12341-12351, 2020 | 65 | 2020 |
| Dot Blot Analysis for Measuring Global N6-Methyladenosine Modification of RNA A Nagarajan, R Janostiak, N Wajapeyee Epitranscriptomics: Methods and Protocols, 263-271, 2019 | 59 | 2019 |
| Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness R Janoštiak, O Tolde, Z Brůhová, M Novotný, SK Hanks, D Rösel, ... Molecular biology of the cell 22 (22), 4256-4267, 2011 | 59 | 2011 |
| Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression P Malvi, R Janostiak, A Nagarajan, G Cai, N Wajapeyee PLoS Genetics 15 (10), e1008439, 2019 | 45 | 2019 |
| Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation R Janostiak, M Vyas, AF Cicek, N Wajapeyee, M Harigopal Experimental and molecular pathology 105 (1), 41-49, 2018 | 39 | 2018 |
| Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease M Bisserier, R Janostiak, F Lezoualc’h, L Hadri Vascular Biology 2 (1), R17-R34, 2020 | 32 | 2020 |
| Transcriptional regulators and alterations that drive melanoma initiation and progression R Gupta, R Janostiak, N Wajapeyee Oncogene 39 (48), 7093-7105, 2020 | 30 | 2020 |
| LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1 P Malvi, R Janostiak, S Chava, P Manrai, E Yoon, K Singh, M Harigopal, ... Oncogenesis 9 (8), 77, 2020 | 29 | 2020 |
| Epigenetic mechanisms dictating eradication of cancer by natural killer cells S Bugide, R Janostiak, N Wajapeyee Trends in cancer 4 (8), 553-566, 2018 | 29 | 2018 |
| N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production P Malvi, R Janostiak, A Nagarajan, X Zhang, N Wajapeyee Molecular metabolism 48, 101217, 2021 | 21 | 2021 |
| ARHGAP42 is activated by Src-mediated tyrosine phosphorylation to promote cell motility W Luo, R Janoštiak, O Tolde, LM Ryzhova, L Koudelková, M Dibus, ... Journal of cell science 130 (14), 2382-2393, 2017 | 21 | 2017 |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development J Dave, V Jagana, R Janostiak, M Bisserier Journal of Translational Medicine 21 (1), 477, 2023 | 17 | 2023 |
| Understanding retinoblastoma post-translational regulation for the design of targeted cancer therapies R Janostiak, A Torres-Sanchez, F Posas, E de Nadal Cancers 14 (5), 1265, 2022 | 16 | 2022 |
| Anaplastic lymphoma kinase confers resistance to BRAF kinase inhibitors in melanoma R Janostiak, P Malvi, N Wajapeyee Iscience 16, 453-467, 2019 | 16 | 2019 |
| CIP/KIP and INK4 families as hostages of oncogenic signaling L Csergeová, D Krbušek, R Janoštiak Cell Division 19 (1), 11, 2024 | 8 | 2024 |
| RNA modification regulatory genes in DNA damage R Janostiak, N Wajapeyee Epitranscriptomics: Methods and Protocols, 249-262, 2019 | 6 | 2019 |
| Educate, not kill: treating cancer without triggering its defenses A Škarková, M Bizzarri, R Janoštiak, J Mašek, D Rosel, J Brábek Trends in Molecular Medicine, 2024 | 2 | 2024 |
